Clinical Trial

Neuromodulation and Attention Deficits in MDD

Recruiting
View on ClinicalTrials.gov →
Summary
Multimodal study (Behavior, TMS, EEG) combining a sham-controlled intermittent theta burst stimulation (iTBS) intervention with an additional-singleton task and EEG to evaluate whether left dorsolateral prefrontal cortex (DLPFC) stimulation enhances cognitive control and modulates maladaptive attention processes in MDD and whether the effects are influenced by neuronavigated versus manual (Beam F3 method) localization of the stimulation site.
Trial Details
NCT Number NCT07111169
Lead Sponsor University of Electronic Science and Technology of China
Conditions Major Depression Disorder, Cognitive Deficits, Selective Attention
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2028-12-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-08